Jordan

 

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

UAE homecare group Manzil expands to Qatar

TVM Capital-owned Manzil Home Health Services, which provides homecare services in the UAE and Egypt, has entered Qatar and eyes further expansion in Saudi Arabia and Turkey. Hoda Abou-Jamra, co-founder of TVM Capital Healthcare Partners, explains why those markets are very different.

Puzzles in Aster DM’s red herring prospectus

Middle East and Indian hospitals to pharmacy chain Aster DM’s red herring IPO prospectus begs as many questions as it answers. Why is EBITDA so low? Will its founder escape criminal charges? Why does it not include full financial year data? So how can it be worth 16,000 crores (an eye watering $2.4bn), that is more than Narayana and Fortis put together?

IDH soars to $900m after London IPO

Shares in the Egyptian lab group Integrated Diagnostic Holdings (IDH) have rocketed 35% to $6 per share in the two weeks since its IPO in London. The IPO at the very top of its indicative price range, valued IDH at 13.8 times 2014 EBITDA. It is now worth over $900m – a historic EBITDA multiple of 17.

Report: Turkish government drives medical tourism

The Turkish government sees medical tourism as a key source of foreign exchange and has put in place measures to support the industry. Revenue from the sector is expected to contribute $20bn per year under the government’s 2023 vision, which marks 100 years since the birth of the Turkish state. Healthcare Europa ask what this means for the industry and who can be expected to benefit.

From Around The World

Here is our weekly round up of private healthcare news from around the Developing World. This week, stories from China, India and the UAE.

IDH announces London IPO in February

Egyptian lab group IDH (Integrated Diagnostics Holdings) is using Egypt’s more settled political situation to cash in on mega-profits. The group expects a market capitalisation of $600m at IPO and could float up to 45% of the share capital. Before tax profits came to $21m, a margin of 25%, in the financial year ending 30 Sep 2014, on sales of $87m, up 27.5%. EBITDA margin stands at 42%.

Find Us